The Latest From CureMatch
CureMatch, Inc., a leader in precision medicine digital decision support solutions, along with authors from esteemed healthcare organizations, released an abstract presenting new research on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment for the 2021 ASCO Annual Meeting, held online June 4-8, 2021. The abstract is titled, “Significance of Scores Generated by a […]
CureMatch, inc. is a digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients….Read More See Full Article Here
Cancer is a devastating disease and treating it can be complex. A single drug is often not adequate to treat many cancer cases. Often, combinations are needed to have and understand data that will help them determine which combination might bets match the genomic or immune abnormalities driving a particular patient’s cancer. CureMatch, as a […]
CureMatch, Inc., a leader in precision digital medicine, announces that Razelle Kurzrock, MD, is presenting insights on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment during the American Association for Cancer Research (AACR) all-virtual Annual Meeting 2021, Week 2, May 17-21, 2021. Board-certified medical oncologist, practicing physician and researcher, Dr. Kurzrock has led the […]
Santa Monica-based Quantgene Inc., which is developing a genetic testing technology that can detect cancer through a blood sample, has formed a partnership with San Diego-based cancer therapy guidance company CureMatch Inc. to improve treatments for cancer. The partnership announced March 24 will allow both companies to use their artificial intelligence technologies to provide more […]